Does PEMBROLIZUMAB Cause Off label use? 3,416 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,416 reports of Off label use have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 4.1% of all adverse event reports for PEMBROLIZUMAB.
3,416
Reports of Off label use with PEMBROLIZUMAB
4.1%
of all PEMBROLIZUMAB reports
747
Deaths
1,045
Hospitalizations
How Dangerous Is Off label use From PEMBROLIZUMAB?
Of the 3,416 reports, 747 (21.9%) resulted in death, 1,045 (30.6%) required hospitalization, and 207 (6.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 3,416 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
Hypothyroidism (2,326)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PEMBROLIZUMAB Alternatives Have Lower Off label use Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G